Abstract
Preclinical and clinical data on atorvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, indicate that it has superior activity in treating a variety of dyslipidemic disorders characterized by elevations in low-density lipoprotein cholesterol (LDL-C) and/or triglycerides. Results for patients randomized in early efficacy and safety studies were combined in one database and analyzed. This analysis included a total of 231 atorvastatin-treated patients (131 with hypercholesterolemia (HC), 63 with combined hyperlipidemia (CH), 36 with hypertriglyceridemia (HTG), and 1 with hyperchylomicronemia (Fredrickson Type V)). Patients were treated with a cholesterol-lowering diet (National Institutes of Health National Cholesterol Education Program Step 1 diet or a more rigorous diet) and either 2.5, 5, 10, 20, 40, or 80 mg/day of atorvastatin or placebo. Efficacy was based on percent change from baseline in total cholesterol, total triglycerides, LDL-C, very low-density lipoprotein cholesterol (VLDL-C), high-density lipoprotein cholesterol (HDL-C), apolipoprotein B (apo B), and non-HDL-C/HDL-C. Safety was assessed in all randomized patients. Atorvastatin seemed to preferentially lower those lipid and lipopro...Continue Reading
References
Mar 7, 1992·Lancet·G F WattsA V Swan
Jun 11, 1992·Circulation·J J GenestE J Schaefer
Jan 1, 1992·Archives of Internal Medicine·S M Grundy, G L Vega
Jan 1, 1991·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·M A Austin
Jul 31, 1990·Biochemical and Biophysical Research Communications·M K ShawB R Krause
Oct 4, 1990·The New England Journal of Medicine·H BuchwaldR D Smink
Sep 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·G L Vega, S M Grundy
Nov 8, 1990·The New England Journal of Medicine·G BrownH T Dodge
Aug 1, 1988·The American Journal of Cardiology·W C Roberts
Nov 12, 1987·The New England Journal of Medicine·M H FrickV Manninen
Nov 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·P T MaM S Brown
Feb 1, 1984·Circulation·J F BrensikeD J Moriarty
Jan 20, 1984·JAMA : the Journal of the American Medical Association
Jan 1, 1981·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·S Stender, D B Zilversmit
Jun 19, 1980·The New England Journal of Medicine·S B HulleyR J Brand
Nov 16, 1995·The New England Journal of Medicine·J ShepherdC J Packard
Aug 1, 1995·Journal of the American College of Cardiology·H BuchwaldS E Williams
May 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·J W NawrockiD M Black
Mar 1, 1996·Journal of Clinical Pharmacology·D M GibsonL R Whitfield
Oct 1, 1995·Atherosclerosis·B R Krause, R S Newton
Jan 26, 1996·Atherosclerosis·R P NaoumovaG R Thompson
Apr 1, 1996·Journal of Cardiovascular Pharmacology and Therapeutics·T M HeinonenD M Black
Citations
Jun 28, 2001·Atherosclerosis·T FunatsuK Miyata
Aug 14, 2001·Atherosclerosis·J Pedro-BotetJ M Ordovas
Sep 16, 1999·Atherosclerosis·N Hoogerbrugge, H Jansen
Mar 30, 1999·Journal of Internal Medicine·N Hoogerbrugge
Mar 30, 1999·Journal of Internal Medicine·H C GeissP Schwandt
Jul 23, 1998·Australian and New Zealand Journal of Medicine·L A Simons
Jun 20, 2006·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Pedro Plans-Rubió
Sep 8, 2010·Clinical Pharmacokinetics·Rajesh NarwalSara E Rosenbaum
Nov 26, 2010·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Pedro Plans-Rubió
Feb 18, 2014·Bioelectrochemistry·Zahra Kamalzadeh, Saeed Shahrokhian
Feb 26, 2013·Colloids and Surfaces. B, Biointerfaces·Jyothi C Abbar, Sharanappa T Nandibewoor
May 13, 2008·Urology·Humberto J Martinez-SuarezGary J Faerber
Apr 9, 2008·European Journal of Internal Medicine·Inbal AvisarEfrat Wolfovitz
Mar 11, 2005·Neurologic Clinics·Ronan J Walsh, Anthony A Amato
Jan 1, 2013·Clinical Therapeutics·Sang-Hyun KimHyo-Soo Kim
Aug 24, 2016·Expert Review of Cardiovascular Therapy·Maria DrakopoulouDimitrios Tousoulis
Oct 28, 2016·Pharmacogenetics and Genomics·Nikolaos TsamandourasLeon Aarons
Mar 28, 2003·The Annals of Pharmacotherapy·Gurhan KadikoyluZahit Bolaman
Jan 15, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·M GuerinM J Chapman
Aug 10, 2000·Obesity Research·B E Levin
Sep 30, 2000·Obesity Research·T A WaddenC M Steinberg
Jun 11, 2002·Obesity Research·Suzanne Phelan, Thomas A Wadden
Mar 11, 2000·Obesity Research·G E CuellarA Berber
Nov 11, 2011·CNS Neuroscience & Therapeutics·Nikhil NihalaniJames L Megna
Aug 4, 1998·Obesity Research·T A WaddenJ L Aber
Jun 20, 2002·Pharmazie in unserer Zeit·Eugen J Verspohl
Dec 18, 2001·Health Economics·D A HughesT Walley
Dec 22, 1999·Endocrine Reviews·G A Bray, F L Greenway
Apr 27, 1999·British Journal of Pharmacology·I P ConnoleyM J Stock
Jul 27, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·L Campbell, S Rössner
May 20, 2020·Cellular and Molecular Bioengineering·Mahsa KheradmandiAmir M Farnoud
Sep 1, 1999·Alimentary Pharmacology & Therapeutics·A Cahill, M E Lean